Distinct patterns of heparin affinity chromatography VLDL1 and VLDL2 subfractions in the different dyslipidaemias

Atherosclerosis

Volumn 199, Issue 1, 2008, Pages 27-33

  Duvillard, L ^a,b   Caslake, M J ^d   Petit, J M ^a,b,c   Verges B ^a,b,c   Gambert, P ^a,b   Packard, C J ^d  

^a INSERM   (France)

^b UNIVERSITÉ DE BOURGOGNE   (France)

^c HÔPITAL DU BOCAGE   (France)

^d GLASGOW ROYAL INFIRMARY   (United Kingdom)

Author keywords

Heparin affinity chromatography; Hypercholesterolaemia; Hypertriglyceridaemia; Mixed hyperlipidaemia; Very low density lipoprotein

Indexed keywords

HEPARIN; LOW DENSITY LIPOPROTEIN CHOLESTEROL; TRIACYLGLYCEROL; VERY LOW DENSITY LIPOPROTEIN;

ADULT; AFFINITY CHROMATOGRAPHY; ARTICLE; FEMALE; HUMAN; HYPERCHOLESTEROLEMIA; HYPERLIPIDEMIA; HYPERTRIGLYCERIDEMIA; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL;

ADULT; ANTICOAGULANTS; APOLIPOPROTEINS B; CHROMATOGRAPHY, AFFINITY; DYSLIPIDEMIAS; FEMALE; HEPARIN; HUMANS; HYPERCHOLESTEROLEMIA; HYPERLIPIDEMIA, FAMILIAL COMBINED; HYPERTRIGLYCERIDEMIA; LIPOPROTEINS, VLDL; MALE; MIDDLE AGED; PROTEIN BINDING; ULTRACENTRIFUGATION;

EID: 45449116731     PISSN: 00219150     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.atherosclerosis.2007.11.026     Document Type: Article

References (26)

1. Cohn J.S., Marcoux C., and Davignon J. Detection, quantification, and characterization of potentially atherogenic triglyceride-rich remnant lipoproteins. Arterioscler Thromb Vasc Biol 19 (1999) 2474-2486
2. Packard C.J., and Shepherd J. Lipoprotein heterogeneity and apolipoprotein B metabolism. Arterioscler Thromb Vasc Biol 17 (1997) 3542-3556
3. Adiels M., Olofsson S.O., Taskinen M.R., and Boren J. Diabetic dyslipidaemia. Curr Opin Lipidol 17 (2006) 238-246
4. Trezzi E., Calvi C., Roma P., and Catapano A.L. Subfractionation of human very low density lipoproteins by heparin-Sepharose affinity chromatography. J Lipid Res 24 (1983) 790-795
5. Huff M.W., and Telford D.E. Characterization and metabolic fate of two very-low-density lipoprotein subfractions separated by heparin-sepharose chromatography. Biochim Biophys Acta 796 (1984) 251-261
6. Campos E., Jackle S., Chi Chen G., and Havel R.J. Isolation and characterization of two distinct species of human very low density lipoproteins lacking apolipoprotein E. J Lipid Res 37 (1996) 1897-1906
7. Evans A.J., Huff M.W., and Wolfe B.M. Accumulation of an apoE-poor subfraction of very low density lipoprotein in hypertriglyceridemic men. J Lipid Res 30 (1989) 1691-1701
8. Barrett P.H., Baker N., and Nestel P.J. Model development to describe the heterogeneous kinetics of apolipoprotein B and triglyceride in hypertriglyceridemic subjects. J Lipid Res 32 (1991) 743-762
9. James R.W., Martin B., Pometta D., et al. Apolipoprotein B metabolism in homozygous familial hypercholesterolemia. J Lipid Res 30 (1989) 159-169
10. Friedewald W.T., Levy R.I., and Fredrickson D.S. Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. Clin Chem 18 (1972) 499-502
11. Lagrost L. Regulation of cholesteryl ester transfer protein (CETP) activity: review of in vitro and in vivo studies. Biochim Biophys Acta 1215 (1994) 209-236
12. Guerin M., Le Goff W., Lassel T.S., et al. Atherogenic role of elevated CE transfer from HDL to VLDL(1) and dense LDL in type 2 diabetes: impact of the degree of triglyceridemia. Arterioscler Thromb Vasc Biol 21 (2001) 282-288
13. Bilz S., Wagner S., Schmitz M., et al. Effects of atorvastatin versus fenofibrate on apoB-100 and apoA-I kinetics in mixed hyperlipidemia. J Lipid Res 45 (2004) 174-185
14. Packard C.J., Munro A., Lorimer A.R., Gotto A.M., and Shepherd J. Metabolism of apolipoprotein B in large triglyceride-rich very low density lipoproteins of normal and hypertriglyceridemic subjects. J Clin Invest 74 (1984) 2178-2192
15. Gaw A., Packard C.J., Lindsay G.M., et al. Overproduction of small very low density lipoproteins (Sf 20-60) in moderate hypercholesterolemia: relationships between apolipoprotein B kinetics and plasma lipoproteins. J Lipid Res 36 (1995) 158-171
16. Packard C.J., Demant T., Stewart J.P., et al. Apolipoprotein B metabolism and the distribution of VLDL and LDL subfractions. J Lipid Res 41 (2000) 305-318
17. Kashyap M.L., Srivastava L.S., Hynd B.A., Gartside P.S., and Perisutti G. Quantitation of human apolipoprotein C-III and its subspecie by radioimmunoassay and analytical isoelectric focusing: abnormal plasma triglyceride-rich lipoprotein apolipoprotein C-III subspecie concentrations in hypertriglyceridemia. J Lipid Res 22 (1981) 800-810
18. Fredenrich A., Giroux L.M., Tremblay M., et al. Plasma lipoprotein distribution of apoC-III in normolipidemic and hypertriglyceridemic subjects: comparison of the apoC-III to apoE ratio in different lipoprotein fractions. J Lipid Res 38 (1997) 1421-1432
19. Batal R., Tremblay M., Barrett P.H., et al. Plasma kinetics of apoC-III and apoE in normolipidemic and hypertriglyceridemic subjects. J Lipid Res 41 (2000) 706-718
20. Marcoux C., Tremblay M., Nakajima K., Davignon J., and Cohn J.S. Characterization of remnant-like particles isolated by immunoaffinity gel from the plasma of type III and type IV hyperlipoproteinemic patients. J Lipid Res 40 (1999) 636-647
21. Windler E., and Havel R.J. Inhibitory effects of C apolipoproteins from rats and humans on the uptake of triglyceride-rich lipoproteins and their remnants by the perfused rat liver. J Lipid Res 26 (1985) 556-565
22. Clavey V., Lestavel-Delattre S., Copin C., Bard J.M., and Fruchart J.C. Modulation of lipoprotein B binding to the LDL receptor by exogenous lipids and apolipoproteins CI, CII, CIII, and E. Arterioscler Thromb Vasc Biol 15 (1995) 963-971
23. Wang C.S., McConathy W.J., Kloer H.U., and Alaupovic P. Modulation of lipoprotein lipase activity by apolipoproteins. Effect of apolipoprotein C-III. J Clin Invest 75 (1985) 384-390
24. Ginsberg H.N., Le N.A., Goldberg I.J., et al. Apolipoprotein B metabolism in subjects with deficiency of apolipoproteins CIII and AI. Evidence that apolipoprotein CIII inhibits catabolism of triglyceride-rich lipoproteins by lipoprotein lipase in vivo. J Clin Invest 78 (1986) 1287-1295
25. Weisgraber K.H., and Rall Jr. S.C. Human apolipoprotein B-100 heparin-binding sites. J Biol Chem 262 (1987) 11097-11103
26. Ishikawa Y., Fielding C.J., and Fielding P.E. A change in apolipoprotein B expression is required for the binding of apolipoprotein E to very low density lipoprotein. J Biol Chem 263 (1988) 2744-2749